Sutro Biopharma (STRO)'s 30-day implied volatility (IV30) was 89.4% at the close on November 3, 2026, down from 96.5% the day before, against a 52-week range of 62.0% to 155.7%. Its 20-day historical volatility was 110.0%.
Data as of November 3, 2026.